Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · IEX Real-Time Price · USD
2.300
-0.170 (-6.88%)
At close: Apr 12, 2024, 4:00 PM
2.250
-0.050 (-2.17%)
After-hours: Apr 12, 2024, 4:21 PM EDT

Atai Life Sciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
45.03190.61362.2797.2530.06
Short-Term Investments
134.7382.50.910.238.24
Cash & Cash Equivalents
179.76273.11363.1897.4738.31
Cash Growth
-34.18%-24.80%272.60%154.46%-
Other Current Assets
5.8314.0411.92.080.84
Total Current Assets
185.59287.15375.0899.5539.15
Property, Plant & Equipment
2.21.150.150.070.02
Long-Term Investments
102.9614.0231.5910.0222.95
Other Long-Term Assets
2.723.137.341.910
Total Long-Term Assets
107.8918.339.081222.97
Total Assets
293.48305.44414.17111.5562.12
Accounts Payable
4.592.463.080.69
Current Debt
0.280.18000
Other Current Liabilities
15.2617.3214.939.220.92
Total Current Liabilities
20.1219.920.9412.31.61
Long-Term Debt
18.8715.160.742.180.16
Other Long-Term Liabilities
10.184.626.531.710.57
Total Long-Term Liabilities
29.0419.787.273.880.73
Total Liabilities
49.1639.6828.2116.182.34
Total Debt
19.1415.340.742.180.16
Debt Growth
24.78%1964.74%-65.87%1286.62%-
Retained Earnings
-550.94-510.19-357.8-190-20.15
Comprehensive Income
-19.46-21.7-8.345.82-1.43
Shareholders' Equity
242.96260.74376.9190.8258.75
Net Cash / Debt
160.62257.77362.4495.338.15
Net Cash / Debt Growth
-37.69%-28.88%280.33%149.80%-
Net Cash Per Share
1.011.662.621.020.44
Working Capital
165.47267.25354.1587.2537.54
Book Value Per Share
1.531.672.730.980.68
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).